USE OF PLACEBO SURGERY IN CONTROLL ...

USE OF PLACEBO SURGERY IN CONTROLL TRIALS OF A CELLULAR-BASED THERAPY FOR PARKINSON'S DISEASE T B Freeman et al The of the present day England Journal of Medicine Vol 341 (September 1999) 988-991

The use of placebo medications in medication evaluation studies is well known and documented in the literature. In as it was studies, participants are made aware that randomization will come into view and that they have an equal chance to receive either a placebo or the reflection medication. Subjects typically have a condition or disease that includes them in the research criteria, and they often room for expectation to receive the study medication in such a manner that they may benefit directly through participating.

Ethical issues in research frequently deal with justice or equality. the same might ask, "If a medication potentially is proper why not administer it to all patients who agree and suited the inclusion criteria of the study?" The answer move round a centres around scientific rigor, which addresses the meanss and protocols used relative to the validity, reliability, biases, or other variables that can make application of mind results generally applicable to reality. Other ethical issues include beneficence (ie, to do good) and nonmaleficence (ie, to do no harm). It is frisked that participating in a contemplation provides more good than harm onward a benefit/burden scale of assessment to each participant.

of recent origin surgical procedures often are introduced onward the basis of uncontrolled studies (ie, without being compared to a placebo surgery) This is because the standard for evaluating surgical measures is lower due to the complexity of designing and conducting valid and ethically acceptable research. Would patients want to suffer a "fake" or placebo surgery that involves having to go through anesthesia and unnecessary surgical intervention? Instead of this option, chiefly research participants would prefer and nothing else to take a placebo medication. Researchers of this inquiry questioned whether the use of placebo surgery is appropriate in present research methodologies.

sense and methods. This article does not report actual cogitation data. Instead, it provides the scientific and ethical rationale for using an imitation surgical process as a placebo control in a double-blind trial of fetal-tissue transplantation in patients with Parkinson's disease. According to the authors, trials that proffer the most effective method to superintendence investigator bias are those that are

* randomized (ie, similar to the toss of a coin),

* double-blind (ie, neither subdues nor investigators know who is receiving which treatment in the study) and

* placebo controll (ie, using a placebo as a data comparison factor).

The authors report their research to date relative to deeds methodology, and participants. Surgical measures for administering cellular-based or medication-based therapies watch to be less invasive, painful, troublesome and risky than traditional surgical orders In addition, these procedures are easier to perform, standardize, and replicate because they do not entail the highly variable manipulation or removal of tissues. As a follow studies of these procedures are les likely to be confuse with each othered by variability in surgeons' skills, and comes are more likely to be generalizable. The authors argue that cellular-based therapy is likened more closely to pharmaceutical evaluations than to surgical procedures

Thirty-six suitable (ie, able to comprehend and demonstrate understanding and decision-making ability regarding treatment options and subject of attention participation) adults with advanced Parkinson's disease, whose symptoms could not be satisfactorily controll with medical therapy, complianceed to be assigned randomly to bear one of three procedures:

* bilateral fetal nigral transplantation with tissue from single in kind donor per side,

* bilateral transplantation with tissue from four donors by side, or

* bilateral placebo surgery

Data analysis would be based onward a total sample of 36 make liables (ie, 12 per group) that provided 80% power of the proof to detect differences between the assemblages with an alpha level of les than 005 and an independent sample two-tailed t test

Each placebo conduct would include the placement of a stereotactic frame, target localization in succession magnetic resonance imaging, the administration of general anesthesia with a laryngeal-mask airway, a skin incision that did not penetrate the inner cortex of the brain, and no implanted fetal tissue. All controls would receive low-dose cyclosporine for six month and would continue to receive medical therapy.

consequence s Although the authors do not have outcomes of their proposed study, they conclud that risks to their participants were minimal and that benefits of participating in the placebo form into groups included

* contributing to advances in the treatment of a disease of great personal interest to the subjects

* receiving standard medical treatment at no cost

* having the opportunity to obtain a fetal-tissue transplant at no costliness if the procedure proved to be safe and effective, and